Shares of Humana Inc. HUM rallied 1.65% to $295.04 Friday, on what proved to be an all-around favorable trading session for ...

Barclays raised the firm’s price target on Humana (HUM) to $322 from $270 and keeps an Equal Weight rating on the shares. The firm revised up ...

In a report released today, Andrew Mok CFA from Barclays maintained a Hold rating on Humana (HUM – Research Report), with a price target of ...

This was the stock's fourth consecutive day of gains.

Humana Inc. can proceed with a lawsuit alleging two Texas medical equipment suppliers owe it about $2.8 million after filing ...

Let’s dig into the relative performance of Humana (NYSE:HUM) and its peers as we unravel the now-completed Q4 health ...

Humana's stock has shown resilience, boosted by a 5% increase in Medicare Advantage payments. Read my analysis of HUM stock.

UnitedHealth Group Incorporated UNH and Humana Inc. HUM are two of the most prominent players in the U.S. health insurance ...

The healthcare stock at just under $282 per share and had been as much as 17% higher at the open, but till held onto most of ...

Chip stocks rallied midday Tuesday, with Broadcom (AVGO) getting a particular boost after it authorized a $ ...

The Centers for Medicare & Medicaid Services projects a 5.06% increase in payments, driven by new data on fee-for-service expenditures and enrollment trends.

The Dow, S&P 500, and Nasdaq fell Tuesday, as the stock market's morning rally evaporated amid uncertainty around President Donald Trump's tariffs.